Bexsero’s price reduced after GlaxoSmithKline buys it from Novartis
Blog from healthcare psychologist Professor John Weinman, Kings College London
Lung drug Zykadia sets sights on UK Early Access to Medicines Scheme as firm also signs $200m cancer deal
Collaboration sees the two firms develop robotic tools to benefit surgeons, patients and healthcare systems
You are invited to take part in the 2015 European Life Sciences Industry Survey on Customer Data.